CareCloud (CCLD) Competitors

$1.08
+0.02 (+1.90%)
(As of 05:27 PM ET)

CCLD vs. LFLY, GSDI, KALA, HUGE, SSKN, NRXS, NRSN, FLGC, PMCB, and AKLI

Should you be buying CareCloud stock or one of its competitors? The main competitors of CareCloud include Leafly (LFLY), Global System Dynamics (GSDI), KALA BIO (KALA), FSD Pharma (HUGE), STRATA Skin Sciences (SSKN), NeurAxis (NRXS), NeuroSense Therapeutics (NRSN), Flora Growth (FLGC), PharmaCyte Biotech (PMCB), and Akili (AKLI). These companies are all part of the "medical" sector.

CareCloud vs.

CareCloud (NASDAQ:CCLD) and Leafly (NASDAQ:LFLY) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, media sentiment, profitability, valuation, dividends, analyst recommendations, risk and community ranking.

CareCloud received 2 more outperform votes than Leafly when rated by MarketBeat users. Likewise, 62.50% of users gave CareCloud an outperform vote while only 37.50% of users gave Leafly an outperform vote.

CompanyUnderperformOutperform
CareCloudOutperform Votes
5
62.50%
Underperform Votes
3
37.50%
LeaflyOutperform Votes
3
37.50%
Underperform Votes
5
62.50%

Leafly has a net margin of -22.48% compared to CareCloud's net margin of -41.58%. Leafly's return on equity of 0.00% beat CareCloud's return on equity.

Company Net Margins Return on Equity Return on Assets
CareCloud-41.58% -60.57% -42.18%
Leafly -22.48%N/A -39.85%

Leafly has lower revenue, but higher earnings than CareCloud. Leafly is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareCloud$117.06M0.15-$48.67M-$4.07-0.27
Leafly$42.25M0.11-$9.50M-$4.92-0.41

In the previous week, CareCloud and CareCloud both had 2 articles in the media. CareCloud's average media sentiment score of 0.50 beat Leafly's score of 0.15 indicating that CareCloud is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CareCloud
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Leafly
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

10.2% of CareCloud shares are owned by institutional investors. Comparatively, 15.6% of Leafly shares are owned by institutional investors. 34.4% of CareCloud shares are owned by company insiders. Comparatively, 11.3% of Leafly shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

CareCloud has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, Leafly has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500.

CareCloud presently has a consensus target price of $3.17, indicating a potential upside of 193.18%. Leafly has a consensus target price of $6.00, indicating a potential upside of 194.12%. Given Leafly's higher probable upside, analysts plainly believe Leafly is more favorable than CareCloud.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareCloud
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Leafly
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

CareCloud beats Leafly on 10 of the 16 factors compared between the two stocks.

Get CareCloud News Delivered to You Automatically

Sign up to receive the latest news and ratings for CCLD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCLD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CCLD vs. The Competition

MetricCareCloudPrepackaged software IndustryMedical SectorNASDAQ Exchange
Market Cap$17.41M$21.28B$4.84B$7.63B
Dividend YieldN/A2.17%2.97%3.94%
P/E Ratio-0.27112.64197.9117.88
Price / Sales0.158.712,284.2082.61
Price / Cash1.7065.6846.5435.09
Price / Book0.419.614.764.38
Net Income-$48.67M$372.81M$102.99M$213.88M
7 Day Performance-5.25%4.50%0.78%1.85%
1 Month Performance-6.89%-1.59%-6.17%-3.73%
1 Year Performance-66.77%21.35%10.15%9.36%

CareCloud Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFLY
Leafly
1.5608 of 5 stars
$2.13
-2.7%
$6.00
+181.7%
-69.3%$4.90M$42.25M-0.43130Short Interest ↑
GSDI
Global System Dynamics
0 of 5 stars
$10.69
flat
N/AN/A$35.38MN/A0.00N/A
KALA
KALA BIO
4.1694 of 5 stars
$6.50
+2.7%
$18.00
+176.9%
-60.1%$18.33M$3.89M-0.3643Short Interest ↓
Gap Up
HUGE
FSD Pharma
0 of 5 stars
$0.46
-4.1%
N/A-68.9%$18.28MN/A-0.9917Short Interest ↑
Gap Up
SSKN
STRATA Skin Sciences
1.2514 of 5 stars
$0.54
+1.9%
$3.80
+603.7%
-47.1%$18.58M$33.36M-1.7499Short Interest ↓
Gap Down
NRXS
NeurAxis
0 of 5 stars
$2.82
-11.3%
N/AN/A$18.58M$2.46M-0.6117
NRSN
NeuroSense Therapeutics
0 of 5 stars
$1.36
+0.7%
N/A-40.6%$18.59MN/A-1.6414Short Interest ↑
FLGC
Flora Growth
3.365 of 5 stars
$1.74
+6.1%
$7.00
+302.3%
-64.8%$18.60M$76.07M-0.17337Short Interest ↓
PMCB
PharmaCyte Biotech
0 of 5 stars
$2.13
-4.1%
N/A-29.1%$18.00MN/A-1.782Short Interest ↓
Positive News
AKLI
Akili
3.7323 of 5 stars
$0.24
+4.4%
$4.00
+1,573.6%
-76.8%$18.78M$1.68M-0.3168Short Interest ↓
News Coverage
Positive News

Related Companies and Tools

This page (NASDAQ:CCLD) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners